MA07.11 Drug Price Comparison in Advanced Lung Cancer – High Cost Prices Is Accompanied by Patient Benefits?

Journal of Thoracic Oncology - United States
doi 10.1016/j.jtho.2018.08.375
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Subacute Sensorimotor Neuropathy Accompanied by Anti-Ganglioside GM1 Antibody in a Patient With Lung Cancer

Internal Medicine
Internal MedicineMedicine
2018English

Hepatitis C: When High Drug Prices Preclude Patient Benefit

Cancer
Cancer ResearchOncology
2018English

International Drug Price Comparison by Atc Groups

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Advanced Lung Adenocarcinoma Patient With ERBB2 Amplification Identified by Comprehensive Genomic Profiling Benefits From Trastuzumab

Case Reports in Oncological Medicine
Oncology
2020English

P2.15-17 Patient Care in Advanced Lung Cancer: Unmet Needs

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

High Cancer Drug Prices 4 Years Later-Progress and Prospects

Cancer
Cancer ResearchOncology
2017English

A Case of Lung Cancer Accompanied by Pulmonary Angiomyolipoma and Lymphangioleiomyomatosis

Japanese Journal of Lung Cancer
OncologyRespiratory MedicinePulmonary
2016English

A Case of De Novo Psoriasis Induced by Atezolizumab in a Patient With Advanced Lung Cancer

Journal of Cutaneous Immunology and Allergy
2019English

PCN107 Potential Benefits of Introducing a Companion Diagnostic in Advanced Non-Small Cell Lung Cancer

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy